Identification of Ski as a target for Aurora A kinase

Biochemical and Biophysical Research Communications

Volumn 409, Issue 3, 2011, Pages 539-543

  Mosquera, Jocelyn ^a   Armisen, Ricardo ^a   Zhao, Hongling ^b   Rojas, Diego A ^a   Maldonado, Edio ^a   Tapia, Julio C ^a   Colombo, Alicia ^a   Hayman, Michael J ^b   Marcelain, Katherine ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Aurora A; Ski; Ski phosphorylation

Indexed keywords

AURORA A KINASE; ONCOPROTEIN; SKI PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CENTROSOME; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; MITOSIS; MUTANT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

ANIMALS; CELL LINE, TUMOR; CENTROMERE; CENTROSOME; DNA-BINDING PROTEINS; HEK293 CELLS; HUMANS; IMMUNOPRECIPITATION; MICE; MITOSIS; MUTATION; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS;

EID: 79958228550     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.05.040     Document Type: Article

References (42)

1. Deheuninck J., Luo K. Ski and SnoN, potent negative regulators of TGF-beta signaling. Cell Res. 2009, 19:47-57.
2. Stavnezer E., Barkas A.E., Brennan L.A., Brodeur D., Li Y. Transforming Sloan-Kettering viruses generated from the cloned v-ski oncogene by in vitro and in vivo recombinations. J. Virol. 1986, 57:1073-1083.
3. Li Y., Turck C.M., Teumer J.K., Stavnezer E. Unique sequence, ski, in Sloan-Kettering avian retroviruses with properties of a new cell-derived oncogene. J. Virol. 1986, 57:1065-1072.
4. Fumagalli S., Doneda L., Nomura N., Larizza L. Expression of the c-ski proto-oncogene in human melanoma cell lines. Melanoma Res. 1993, 3:23-27.
5. Reed J.A., Bales E., Xu W., Okan N.A., Bandyopadhyay D., Medrano E.E. Cytoplasmic localization of the oncogenic protein Ski in human cutaneous melanomas in vivo: functional implications for transforming growth factor beta signaling. Cancer Res. 2001, 61:8074-8078.
6. Fukuchi M., Nakajima M., Fukai Y., Miyazaki T., Masuda N., Sohda M., Manda R., Tsukada K., Kato H., Kuwano H. Increased expression of c-Ski as a co-repressor in transforming growth factor-beta signaling correlates with progression of esophageal squamous cell carcinoma. Int. J. Cancer 2004, 108:818-824.
7. Buess M., Terracciano L., Reuter J., Ballabeni P., Boulay J.L., Laffer U., Metzger U., Herrmann R., Rochlitz C. Amplification of SKI is a prognostic marker in early colorectal cancer. Neoplasia 2004, 6:207-212.
8. Ritter M., Kattmann D., Teichler S., Hartmann O., Samuelsson M.K., Burchert A., Bach J.P., Kim T.D., Berwanger B., Thiede C., Jager R., Ehninger G., Schafer H., Ueki N., Hayman M.J., Eilers M., Neubauer A. Inhibition of retinoic acid receptor signaling by Ski in acute myeloid leukemia. Leukemia 2006, 20:437-443.
9. Takahata M., Inoue Y., Tsuda H., Imoto I., Koinuma D., Hayashi M., Ichikura T., Yamori T., Nagasaki K., Yoshida M., Matsuoka M., Morishita K., Yuki K., Hanyu A., Miyazawa K., Inazawa J., Miyazono K., Imamura T. SKI and MEL1 cooperate to inhibit transforming growth factor-beta signal in gastric cancer cells. J. Biol. Chem. 2009, 284:3334-3344.
10. Azuma H., Ehata S., Miyazaki H., Watabe T., Maruyama O., Imamura T., Sakamoto T., Kiyama S., Kiyama Y., Ubai T., Inamoto T., Takahara S., Itoh Y., Otsuki Y., Katsuoka Y., Miyazono K., Horie S. Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells. J. Natl. Cancer Inst. 2005, 97:1734-1746.
11. Poser I., Rothhammer T., Dooley S., Weiskirchen R., Bosserhoff A.K. Characterization of Sno expression in malignant melanoma. Int. J. Oncol. 2005, 26:1411-1417.
12. Le Scolan E., Zhu Q., Wang L., Bandyopadhyay A., Javelaud D., Mauviel A., Sun L., Luo K. Transforming growth factor-beta suppresses the ability of Ski to inhibit tumor metastasis by inducing its degradation. Cancer Res. 2008, 68:3277-3285.
13. Wang P., Chen Z., Meng Z., Fan J., Luo J., Liang W., Lin J., Zhou Z., Chen H., Wang K., Shen Y., Xu Z., Liu L. Dual role of Ski in pancreatic cancer cells: tumor-promoting versus metastasis-suppressive function. Carcinogenesis 2009, 30:1497-1506.
14. Shinagawa T., Nomura T., Colmenares C., Ohira M., Nakagawara A., Ishii S. Increased susceptibility to tumorigenesis of ski-deficient heterozygous mice. Oncogene 2001, 20:8100-8108.
15. K. Marcelain, R. Armisen, A. Aguirre, N. Ueki, J. Toro, C. Colmenares, M.J. Hayman, Chromosomal instability in mouse embryonic fibroblasts null for the transcriptional co-repressor Ski, J. Cell. Physiol.
16. Macdonald M., Wan Y., Wang W., Roberts E., Cheung T.H., Erickson R., Knuesel M.T., Liu X. Control of cell cycle-dependent degradation of c-Ski proto-oncoprotein by Cdc34. Oncogene 2004, 23:5643-5653.
17. Marcelain K., Hayman M.J. The Ski oncoprotein is upregulated and localized at the centrosomes and mitotic spindle during mitosis. Oncogene 2005, 24:4321-4329.
18. Ditchfield C., Johnson V.L., Tighe A., Ellston R., Haworth C., Johnson T., Mortlock A., Keen N., Taylor S.S. Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores. J. Cell Biol. 2003, 161:267-280.
19. Zhao H.L., Ueki N., Marcelain K., Hayman M.J. The Ski protein can inhibit ligand induced RARalpha and HDAC3 degradation in the retinoic acid signaling pathway. Biochem. Biophys. Res. Commun. 2009, 383:119-124.
20. Gritsko T.M., Coppola D., Paciga J.E., Yang L., Sun M., Shelley S.A., Fiorica J.V., Nicosia S.V., Cheng J.Q. Activation and overexpression of centrosome kinase BTAK/Aurora-A in human ovarian cancer. Clin. Cancer Res. 2003, 9:1420-1426.
21. Armisen R., Marcelain K., Simon F., Tapia J.C., Toro J., Quest A.F., Stutzin A. TRPM4 enhances cell proliferation through up-regulation of the beta-catenin signaling pathway. J. Cell. Physiol. 2011, 226:103-109.
22. Ueki N., Hayman M.J. Direct interaction of Ski with either Smad3 or Smad4 is necessary and sufficient for Ski-mediated repression of transforming growth factor-beta signaling. J. Biol. Chem. 2003, 278:32489-32492.
23. Mountzios G., Terpos E., Dimopoulos M.A. Aurora kinases as targets for cancer therapy. Cancer Treat. Rev. 2008, 34:175-182.
24. Nigg E.A. Mitotic kinases as regulators of cell division and its checkpoints. Nat. Rev. Mol. Cell Biol. 2001, 2:21-32.
25. Kimura M., Kotani S., Hattori T., Sumi N., Yoshioka T., Todokoro K., Okano Y. Cell cycle-dependent expression and spindle pole localization of a novel human protein kinase, Aik, related to Aurora of Drosophila and yeast Ipl1. J. Biol. Chem. 1997, 272:13766-13771.
26. Shindo M., Nakano H., Kuroyanagi H., Shirasawa T., Mihara M., Gilbert D.J., Jenkins N.A., Copeland N.G., Yagita H., Okumura K. CDNA cloning, expression, subcellular localization, and chromosomal assignment of mammalian aurora homologues, aurora-related kinase (ARK) 1 and 2. Biochem. Biophys. Res. Commun. 1998, 244:285-292.
27. Gopalan G., Chan C.S., Donovan P.J. A novel mammalian, mitotic spindle-associated kinase is related to yeast and fly chromosome segregation regulators. J. Cell Biol. 1997, 138:643-656.
28. Heyman H.C., Stavnezer E. A carboxyl-terminal region of the ski oncoprotein mediates homodimerization as well as heterodimerization with the related protein SnoN. J. Biol. Chem. 1994, 269:26996-27003.
29. Sleeman J.P., Laskey R.A. Xenopus c-ski contains a novel coiled-coil protein domain, and is maternally expressed during development. Oncogene 1993, 8:67-77.
30. Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A., Mann M. Proteomic characterization of the human centrosome by protein correlation profiling. Nature 2003, 426:570-574.
31. Sutrave P., Copeland T.D., Showalter S.D., Hughes S.H. Characterization of chicken c-ski oncogene products expressed by retrovirus vectors. Mol. Cell. Biol. 1990, 10:3137-3144.
32. Nagata M., Nagata S., Yuki K., Isogaya K., Saitoh M., Miyazono K., Miyazawa K. Identification of a phosphorylation site in c-Ski as serine 515. J. Biochem. 2010, 148:423-427.
33. Band A.M., Bjorklund M., Laiho M. The phosphatidylinositol 3-kinase/Akt pathway regulates transforming growth factor-{beta} signaling by destabilizing ski and inducing Smad7. J. Biol. Chem. 2009, 284:35441-35449.
34. Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S. Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach. Anal. Chem. 2009, 81:4493-4501.
35. V. Mayya, D.H. Lundgren, S.I. Hwang, K. Rezaul, L. Wu, J.K. Eng, V. Rodionov, D.K. Han, Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions, Sci. Signal. 2 (2009) ra46.
36. Andrews P.D. Aurora kinases: shining lights on the therapeutic horizon?. Oncogene 2005, 24:5005-5015.
37. Bischoff J.R., Anderson L., Zhu Y., Mossie K., Ng L., Souza B., Schryver B., Flanagan P., Clairvoyant F., Ginther C., Chan C.S., Novotny M., Slamon D.J., Plowman G.D. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J. 1998, 17:3052-3065.
38. Sen S., Zhou H., White R.A. A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines. Oncogene 1997, 14:2195-2200.
39. Miyoshi Y., Iwao K., Egawa C., Noguchi S. Association of centrosomal kinase STK15/BTAK mRNA expression with chromosomal instability in human breast cancers. Int. J. Cancer 2001, 92:370-373.
40. Zhou H., Kuang J., Zhong L., Kuo W.L., Gray J.W., Sahin A., Brinkley B.R., Sen S. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat. Genet. 1998, 20:189-193.
41. Dar A.A., Goff L.W., Majid S., Berlin J., El-Rifai W. Aurora kinase inhibitors - rising stars in cancer therapeutics?. Mol. Cancer Ther. 2010, 9:268-278.
42. Katayama H., Sen S. Aurora kinase inhibitors as anticancer molecules. Biochim. Biophys. Acta 2010, 1799:829-839.